AXIMAxim Biotechnologies, Inc.
Price Chart
Loading chart...
About Axim Biotechnologies, Inc. (AXIM)
Axim Biotechnologies, Inc. (AXIM) is a Biotechnology company headquartered in San Diego, CA, United States whose shares trade over-the-counter on the Pink tier.
Axim Biotechnologies, Inc. is a leading developer of diagnostic healthcare solutions serving to enhance the health of people. Through the development of diagnostic solutions that quickly and accurately diagnose various diseases, our products allow healthcare workers to quickly test and treat at the point-of-care, which leads to improved patient outcomes and provides numerous economic benefits to the healthcare system. Axim's core competencies include development of rapid lateral flow immunoassays, reagents and monoclonal antibody development for such assays.
Products and services
Axim Biotechnologies, Inc. is a leading developer of diagnostic healthcare solutions serving to enhance the health of people. Through the development of diagnostic solutions that quickly and accurately diagnose various diseases, our products allow healthcare workers to quickly test and treat at the point-of-care, which leads to improved patient outcomes and provides numerous economic benefits to the healthcare system. Axim’s core competencies include development of rapid lateral flow immunoassays, reagents and monoclonal antibody development for such assays. Our current products fall into these categories: (1) Eye Health, wherein we acquired two FDA cleared 510(k) tests for dye eye disease and have internally developed a third assay; and (2) SARS-CoV-2 neutralizing antibody tests.
AXIM key facts
- Ticker symbol
- AXIM
- Market tier
- Pink
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- San Diego, CA, United States
- Country of incorporation
- US
- Year of incorporation
- 2010
- Employees
- 8
- Estimated market cap
- $1.46M (as of Apr 10, 2025)
- Shares outstanding
- 332,761,010
- Reporting standard
- Alternative Reporting Standard
- Audit status
- Audited
- Fiscal year end
- 12/31
Axim Biotechnologies, Inc. leadership
- Catalina Valencia — President
- Robert T. Malasek — CFO
- Phillip E Koehnke APC — Corporate Counsel
Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with A
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for Axim Biotechnologies, Inc. (AXIM) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Biotechnology Companies on OTC Markets
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Company Officers
Social Media
Business Details
Stock Details
Loading modules...